Month: July 2024

Release – Graham Corporation Awarded $2.1 Million to Expand Welder Workforce to Support U.S. Navy’s Submarine Industrial Base Program

Posted on by dburczyk@noblecapitalmarkets.com

Research News and Market Data on GHM

BATAVIA, N.Y.–(BUSINESS WIRE)– Graham Corporation (NYSE: GHM) (“GHM” or “the Company”), a global leader in the design and manufacture of mission critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries, announced today that it has been awarded $2.1 million for the expansion of its welder training programs and related equipment. The contract was awarded by BlueForge Alliance, a nonprofit, neutral integrator that supports the U.S. Navy’s Submarine Industrial Base initiatives.

Daniel J. Thoren, President and CEO of GHM, commented, “These are exciting times for our Company as we build out our capabilities and capacity to support America’s defense industry as a part of the U.S. Navy’s Submarine Industrial Base. These funds will help us develop and grow our welder workforce and provide additional equipment needed to improve the efficiency of our production processes. We are proud to be a strategic supplier for the U.S. Navy’s Submarine Industrial Base.”

The funds will be used to increase the Company’s production capacity at its Batavia operation which includes expanding its welding training program and increasing its skilled labor workforce by more than 20 percent. The Company expects to accomplish the workforce expansion by early 2025 to support the U.S. Navy’s submarine construction cadence plans.

About Graham Corporation
Graham is a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy, and process industries. Graham Corporation and its family of global brands are built upon world-renowned engineering expertise in vacuum and heat transfer, cryogenic pumps, and turbomachinery technologies, as well as its responsive and flexible service and the unsurpassed quality customers have come to expect from the Company’s products and systems. Graham Corporation routinely posts news and other important information on its website, grahamcorp.com, where additional information on Graham Corporation and its businesses can be found.

About BlueForge Alliance
BlueForge Alliance is a nonprofit, neutral integrator that supports the U.S. Navy’s Submarine Industrial Base initiatives and efforts to strengthen and sustain the maritime manufacturing sector. BFA is a critical partner in the SIB’s mission to ensure industry has the capability, capacity, and resilience to build and maintain America’s next generation of undersea platforms. The organization’s team of experts in a variety of disciplines focus on addressing critical workforce, technology, and supplier development needs. BFA is headquartered in Bryan/College Station, Texas. For more information, visit www.BlueForgeAlliance.us.

Safe Harbor Regarding Forward Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as “expects,” “anticipates,” “potential,” “will,” and other similar words. All statements addressing operating performance, events, or developments that Graham Corporation expects or anticipates will occur in the future, including but not limited to, winning potential future or multi-year orders, potential revenues and timing of such revenues, capacity, demand growth, and delivering timely or otherwise on schedule are forward-looking statements. Because they are forward-looking, they should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Graham Corporation’s most recent Annual Report filed with the Securities and Exchange Commission, including under the heading entitled “Risk Factors,” its quarterly reports on Form 10-Q, and other filings it makes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize or should any of Graham Corporation’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Graham Corporation’s forward-looking statements. Except as required by law, Graham Corporation disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this news release.

For more information:
Christopher J. Thome
Vice President – Finance and CFO
Phone: (585) 343-2216

Deborah K. Pawlowski
Kei Advisors LLC
Phone: (716) 843-3908
dpawlowski@keiadvisors.com

Source: Graham Corporation

Released July 25, 2024

Release – The ODP Corporation to Announce Second Quarter 2024 Results Wednesday, August 7, 2024

Posted on by dburczyk@noblecapitalmarkets.com

Research News and Market Data on ODP

BOCA RATON, Fla.–(BUSINESS WIRE)–Jul. 24, 2024– The ODP Corporation (NASDAQ:ODP) (“ODP,” or the “Company”), a leading provider of business services, products and digital workplace technology solutions to businesses and consumers, will announce second quarter 2024 financial results before the market open on Wednesday, August 7th, 2024. The ODP Corporation will webcast a call with financial analysts and investors that day at 9:00 am Eastern Time which will be accessible to the media and the general public.

To listen to the conference call via webcast, please visit The ODP Corporation’s Investor Relations website at investor.theodpcorp.com. A replay of the webcast will be available approximately two hours following the event. A copy of the earnings press release, supplemental financial disclosures and presentation will also be available on the website.

About The ODP Corporation

The ODP Corporation (NASDAQ:ODP) is a leading provider of products and services through an integrated business-to-business (B2B) distribution platform and omnichannel presence, which includes world-class supply chain and distribution operations, dedicated sales professionals, a B2B digital procurement solution, online presence and a network of Office Depot and OfficeMax retail stores. Through its operating companies Office Depot, LLC; ODP Business Solutions, LLC; and Veyer, LLC, The ODP Corporation empowers every business, professional, and consumer to achieve more every day. For more information, visit theodpcorp.com.

ODP and ODP Business Solutions are trademarks of ODP Business Solutions, LLC. Office Depot is a trademark of The Office Club, LLC. OfficeMax is a trademark of OMX, Inc. Veyer is a trademark of Veyer, LLC. Varis is a trademark of Varis, Inc. Grand&Toy is a trademark of Grand & Toy, LLC in Canada. Any other product or company names mentioned herein are the trademarks of their respective owners.

Tim Perrott
Investor Relations
561-438-4629
Tim.Perrott@theodpcorp.com

Source: The ODP Corporation

Viking’s Surprise Move in the $150 Billion Weight Loss Race

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Viking Therapeutics stock surges 20% after announcing early advancement to late-stage trials for weight loss drug
– Company’s experimental injection VK2735 shows promising results, potentially rivaling industry giants
– Decision to skip additional mid-stage trial could accelerate drug’s market entry by a year
– Viking also developing a convenient monthly injection and oral version of the drug

In a stunning turn of events, the relatively unknown biotech company Viking Therapeutics has suddenly become the talk of Wall Street. The San Diego-based firm saw its stock price soar by over 20% on Thursday, following a game-changing announcement that has investors and health enthusiasts alike sitting up and taking notice.

The catalyst for this dramatic surge? Viking Therapeutics revealed its plans to fast-track its experimental weight loss injection, VK2735, directly into late-stage trials. This bold move, which comes earlier than expected, has positioned the company as a potential dark horse in the fiercely competitive GLP-1 market, currently dominated by pharmaceutical giants Novo Nordisk and Eli Lilly.

The GLP-1 market, projected to balloon to a staggering $150 billion by the end of the decade, has been a battlefield for drug companies seeking to capitalize on the growing demand for effective weight loss solutions. Viking’s unexpected leap forward has not only caught the attention of investors but also sent ripples through the industry, with shares of both Novo Nordisk and Eli Lilly dipping more than 1% in response.

What makes Viking’s VK2735 so promising? In a phase two trial, patients receiving weekly doses of the injection lost up to 14.7% of their body weight over just 13 weeks – an impressive figure that puts it in the same league as its more established competitors. But Viking isn’t stopping there. The company is also developing a monthly injection version of VK2735, which could offer a more convenient option for patients compared to the weekly regimens of current market leaders.

Adding another layer of intrigue, Viking is simultaneously working on an oral version of VK2735. In early-stage trials, this pill form demonstrated a 3.3% weight loss compared to placebo, opening up the possibility of a non-injectable alternative in the future.

The decision to skip an additional mid-stage trial and move directly to phase three could shave off a significant amount of time from Viking’s development timeline. Analysts now estimate that this strategic move could accelerate the drug’s market entry by as much as a year, potentially launching in 2028 instead of the previously projected 2029.

Viking’s CEO, Brian Lian, expressed confidence in the company’s direction during a recent earnings call, citing positive feedback from the Food and Drug Administration as a key factor in their decision to expedite the development process. The company is now preparing for a crucial meeting with the FDA in the fourth quarter to discuss the design and timing of the phase three trial.

As Viking Therapeutics gears up for this next critical phase, the biotech world watches with bated breath. Could this underdog company be on the verge of disrupting the weight loss drug market? With its promising results and aggressive development strategy, Viking is certainly positioning itself as a formidable contender in the race to capture a slice of the lucrative GLP-1 pie.

For investors and health-conscious individuals alike, the message is clear: keep a close eye on Viking Therapeutics. This small biotech firm might just be holding the key to the next big breakthrough in weight loss treatment.

Maple Gold Mines (MGMLF) – Hitting its Stride and Gaining Momentum

Posted on by cpereira@noblefcm.com


Thursday, July 25, 2024

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Augmenting the leadership team. Effective immediately, Maple Gold Mines Ltd. appointed Mr. Darwin Green, P. Geo., to its Board of Directors. Mr. Ian Cunningham-Dunlop, P. Eng., has been appointed Vice President, Technical Services effective on or before August 1, 2024. Both have impressive credentials which are summarized in the body of this note. As Mr. Kiran Patankar, CEO, has taken quick actions to reposition the company for successful outcomes, Mr. Green and Mr. Cunningham-Dunlop will strengthen the company’s ability to execute. Maple’s Chief Geologist and Engineer will report to Mr. Cunningham-Dunlop.

Upcoming events. We expect the company to hold a meeting of its Board of Directors ahead of releasing its second quarter financial results to the market in early August. On September 9, the company will host its annual meeting of shareholders at which time Maple Gold shareholders will vote on the recent joint venture restructuring transaction with Agnico Eagle Mines Limited (NYSE: AEM). Maple is also expected to provide a more detailed exploration update and plan later in the year prior to commencement of the company’s drilling program.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Tech Giants’ Earnings Disappoint, Causing Stock Market Decline

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Nasdaq falls nearly 3% after disappointing earnings from Alphabet and Tesla
– Tech sector leads market decline, potentially signaling a shift in investor sentiment
– Economic data adds to concerns about U.S. economic health

The U.S. stock market experienced a significant downturn on Wednesday, primarily driven by underwhelming earnings reports from major technology companies. This event highlights the influential role these firms play in overall market performance.

The Nasdaq Composite, which is heavily weighted towards technology stocks, dropped by almost 3%, marking its largest single-day decline since late 2022. The broader S&P 500 index also fell by 1.7%, while the Dow Jones Industrial Average decreased by 0.8%.

Two key players in the tech sector, Alphabet (Google’s parent company) and Tesla, reported earnings that fell short of investor expectations. Alphabet’s shares declined despite beating overall revenue and profit forecasts, as YouTube advertising revenue underperformed. Tesla’s stock price fell more sharply, following weaker-than-anticipated results and a decrease in automotive revenue compared to the previous year.

The disappointing performance of these tech giants had a ripple effect across the sector. Other major technology companies, including Nvidia, Meta Platforms, and Microsoft, also saw their stock prices decline in sympathy.

It’s worth noting that these large technology companies have been the primary drivers of market gains this year. Their outsized influence means that when they underperform, it can have a significant impact on overall market indices.

Interestingly, while large-cap tech stocks struggled, smaller companies showed resilience. The Russell 2000 small-cap index has performed well this month, potentially indicating a shift in investor focus towards a broader range of stocks.

Adding to market concerns, recent economic data painted a mixed picture of the U.S. economy. A report showed manufacturing activity unexpectedly contracting, while new home sales came in below expectations. These indicators raised questions about the overall health of the economy.

However, it’s important to maintain perspective. Despite the disappointing results from some tech giants, the broader earnings season has started positively. Over 25% of S&P 500 companies have reported second-quarter earnings, with about 80% exceeding expectations.

For investors, particularly those new to the market, this event serves as a reminder of the importance of diversification. Relying too heavily on a small group of high-performing stocks can increase risk. It also demonstrates that even the most successful companies can face challenges.

As we move forward, market participants will be closely monitoring upcoming earnings reports and economic data. The next few weeks will be crucial in determining whether this is a temporary setback or the beginning of a more significant market shift.

In conclusion, while days like this can be unsettling, they are a normal part of market dynamics. Understanding these fluctuations and maintaining a balanced, long-term perspective is key to navigating the complexities of the stock market.

Release – Graham Corporation Announces First Quarter Fiscal Year 2025 Financial Results Conference Call and Webcast

Posted on by dburczyk@noblecapitalmarkets.com

Research News and Market Data on GHM

BATAVIA, N.Y.–(BUSINESS WIRE)– Graham Corporation (NYSE: GHM), a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy and process industries, announced that it will release its first quarter fiscal year 2025 financial results before financial markets open on Wednesday, August 7, 2024.

The Company will host a conference call and webcast to review its financial and operating results, strategy, and outlook. A question-and-answer session will follow.

First Quarter Fiscal Year 2025 Financial Results Conference Call

Wednesday, August 7, 2024
11:00 a.m. Eastern Time
Phone: (201) 689-8560
Internet webcast link and accompanying slide presentation: ir.grahamcorp.com

A telephonic replay will be available from 3:00 p.m. ET on the day of the teleconference through Wednesday, August 14, 2024. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13746993 or access the webcast replay via the Company’s website at ir.grahamcorp.com, where a transcript will also be posted once available.

ABOUT GRAHAM CORPORATION

Graham is a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy and process industries. Graham Corporation and its family of global brands are built upon world-renowned engineering expertise in vacuum and heat transfer, cryogenic pumps and turbomachinery technologies, as well as its responsive and flexible service and the unsurpassed quality customers have come to expect from the Company’s products and systems.

Graham routinely posts news and other important information on its website, grahamcorp.com, where additional information on Graham Corporation and its businesses can be found.

For more information, contact:
Christopher J. Thome
Vice President – Finance and CFO
Phone: (585) 343-2216

Deborah K. Pawlowski
Kei Advisors LLC
Phone: (716) 843-3908
dpawlowski@keiadvisors.com

Source: Graham Corporation

Released July 24, 2024

Release – Conduent to Report Second-Quarter 2024 Financial Results on August 7, 2024

Posted on by aweinsoff@channelchek.com

Research News and Market Data on CNDT

JULY 24, 2024

EARNINGS/FINANCIAL

FLORHAM PARK, N.J. — Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, plans to report its second-quarter 2024 financial results on Wednesday, August 7, 2024 before market open. Management will present the results during a conference call and webcast at 9:00 a.m. ET.

The call will be available by live audio cast along with the news release and online presentation slides at https://investor.conduent.com.

The conference call will also be available by calling 877-407-4019 toll free. If requested, the conference ID is 13747159.

The international dial-in is +1 201-689-8337. The international conference ID is also 13747159.

A recording of the conference call will be available by calling 877-660-6853 three hours after the conference call concludes. The access ID for the recording is 13747159.

The call recording will be available until August 21, 2024.

We look forward to your participation.

About Conduent
Conduent delivers digital business solutions and services spanning the commercial, government and transportation spectrum – creating valuable outcomes for its clients and the millions of people who count on them. The Company leverages cloud computing, artificial intelligence, machine learning, automation and advanced analytics to deliver mission-critical solutions. Through a dedicated global team of approximately 59,000 associates, process expertise and advanced technologies, Conduent’s solutions and services digitally transform its clients’ operations to enhance customer experiences, improve performance, increase efficiencies and reduce costs. Conduent adds momentum to its clients’ missions in many ways including disbursing approximately $100 billion in government payments annually, enabling 2.3 billion customer service interactions annually, empowering millions of employees through HR services every year and processing nearly 13 million tolling transactions every day. Learn more at www.conduent.com.

Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.

Trademarks
Conduent is a trademark of Conduent Incorporated in the United States and/or other countries. Other names may be trademarks of their respective owners.

Media Contacts

SEAN COLLINS

Conduent

Sean.Collins2@conduent.com

+1-310-497-9205

GILES GOODBURN

Conduent

ir@conduent.com

+1-203-216-3546

Release – Beyond “One Bug, One Drug” – Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

Posted on by aweinsoff@channelchek.com

Research News and Market Data on TNXP

July 24, 2024 7:45am EDT

CHATHAM, NJ / ACCESSWIRE / July 24, 2024 / From anthrax to the plague, biological warfare is a real threat to U.S. forces and civilians, so much so the Pentagon budgeted about $2 billion for the country’s biological defense for the coming fiscal year. It’s also why the U.S. Department of Defense is seeking broad-spectrum antiviral drugs and teaming up with the biotech companies developing them.

That’s the case with Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a fully integrated biopharmaceutical company. The DoD’s Defense Threat Reduction Agency (DTRA) recently inked a five-year deal with Tonix Pharmaceuticals to develop small molecule broad-spectrum antiviral agents for the prevention or treatment of infections to improve the medical readiness of military personnel in biological threat environments. Through the Other Transaction Agreement (OTA) contracting vehicle, Tonix could get as much as $34 million in funding over five years.

“Through our agreement with DTRA, our broad-spectrum antiviral research program will address the DoD’s goal of protecting U.S. forces in the event biological weapons are introduced onto the battlefield,” said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. “This funding provides important validation for our ongoing research and current in-house capabilities and will enable Tonix to advance its antiviral discovery program.”

Stop Viruses In Their Tracks

Antiviral drugs are designed to stop a virus in its tracks by either attacking it or preventing it from spreading. In the case of Tonix’s program, the goal is to fortify the immune system so that it can protect against a range of viruses. Demand for antiviral drugs is rising along with the concerns about viruses on the battlefield. Viruses are changing, jumping back and forth between humans and animals and there’s the new risk that synthetic biology can be used maliciously, to make new viruses or to make existing viruses more virulent in what’s called “gain of function”. On the battlefield, the DoD is looking for antiviral drugs that can protect soldiers regardless of the agent. It is pouring money into different initiatives designed to react in the event of a biological attack.

Take DTRA’s Chemical and Biological Technologies Department which is sponsoring Tonix’s research. The department, which is funded out of DTRA’s approximately $1.9 billion budget for fiscal 2024, invests in medical countermeasure projects to fulfill its mission to anticipate future threats and equip the warfighter to survive, fight and win in chemical and biological contested environments.

Across the U.S. government, chemical and biological countermeasures programs have approximately $1.26 billion budgeted for fiscal 2024 and includes programs to reduce the risks to both U.S. troops and the global community from bacteria or viruses. The need to slow the spread of viruses and protect troops from biowarfare is just part of an over-all antiviral market estimated to reach $74.75 billion by 2028, growing at a CAGR of 6.19%.

Attacking The CD45 Protein

Tonix Pharmaceuticals’ program will focus on optimizing and developing TNX-4200, the company’s oral CD45 antagonist program, which is designed to have broad-spectrum efficacy against a range of viral pathogens. This broad-spectrum capability is a move beyond the previous “one bug, one drug” approach and seeks to target a broad range of deadly agents through just a single drug. Reduction of CD45 activity, a protein tyrosine phosphatase, protects animals against many viruses, including the Ebola virus. Through this funding, Tonix expects to establish the treatment’s biological activity and safety in animals and then submit an Investigational New Drug application (IND) to conduct a first-in-human phase 1 clinical study.

Tonix said it plans to leverage previous research on phosphatase inhibitors – specifically compounds that target CD45 – to optimize compounds for therapeutic intervention of biothreat agents and provide the government with a broad-spectrum medical countermeasure. The idea behind Tonix’s compound is that partial inhibition of CD45 will provide optimal antiviral protection with an acceptable safety profile. The $34 million, five-year contract will help bankroll and accelerate the development of Tonix’s host-directed antivirals which have the potential to reduce viral load and allow the adaptive immune system to alert the other arms of the immune system to mount a protective response, reports the company.

Leveraging R&D Capabilities

To develop its program, Tonix plans to rely on what it says are state-of-the-art research laboratory capabilities, including a Biosafety Level 3 (BSL-3) lab and an Animal Biosafety Level 3 (ABSL-3) facility at its research and development center in Frederick, Maryland. The research center is located in Maryland’s I-270 biotech corridor and is close to the center of the U.S. biodefense research community. The research facilities will help to accelerate the development of vaccines and antiviral drugs against infectious diseases.

The threat of viruses, pandemics and biochemical attacks is increasing, driving demand for antivirals that can stop pathogens in their tracks. Tonix is betting it can deliver a single remedy to cover several viruses – and has up to $34 million to prove it.

Featured photo by api.army.mil.

Click here for more information on Tonix Pharmaceuticals: https://redingtonvirtual.com/tnxp-aw-24072/

Investor Contact
Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
(862) 904-8182

Important notice, please read: Certain statements in this document are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements are based on Tonix’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, risks related to the failure to obtain FDA clearances or approvals and noncompliance with FDA regulations; risks related to the failure to successfully market any of our products; risks related to the timing and progress of clinical development of our product candidates; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third party payor reimbursement; limited research and development efforts and dependence upon third parties; and substantial competition As with any pharmaceutical under development, there are significant risks in the development, regulatory approval, and commercialization of new products. Tonix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024, and periodic reports filed with the SEC on or after the date thereof. All Tonix’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date thereof. This is not a solicitation of any offer to buy or sell. Redington, Inc. is paid by Tonix Pharmaceuticals Holding Corp. for investor relations services, and its employees or members of their families may from time to time own an equity interest in companies mentioned herein.

SOURCE: Tonix Pharmaceuticals Holding Corp.

View the original press release on accesswire.com

Released July 24, 2024

Ethereum ETFs Debut with $106M Inflow

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Nine Ethereum ETFs launched on U.S. stock exchanges, attracting $106 million in net inflows on the first day
– BlackRock, Bitwise, and Fidelity ETFs saw the highest inflows
– Grayscale’s converted Ethereum Trust experienced significant outflows, likely due to higher fees
– The success of Ethereum ETFs follows the January launch of spot Bitcoin ETFs
– Crypto ETFs could impact traditional stock markets by offering new diversification options

The launch of nine exchange-traded funds (ETFs) tied to the spot price of Ethereum on U.S. stock exchanges marks another significant milestone in the integration of cryptocurrencies into traditional financial markets. On their first day of trading, these ETFs collectively attracted net inflows of $106 million, demonstrating substantial investor interest in gaining exposure to the world’s second-largest cryptocurrency through regulated investment vehicles.

The debut of Ethereum ETFs follows the successful launch of spot Bitcoin ETFs in January 2024, which saw considerable inflows and sparked increased institutional interest in cryptocurrencies. The positive reception of Ethereum ETFs suggests that the appetite for crypto-based investment products extends beyond Bitcoin, potentially paving the way for broader adoption of digital assets in mainstream finance.

Among the new Ethereum ETFs, BlackRock’s iShares Ethereum Trust ETF led the pack with $266.5 million in inflows, followed closely by the Bitwise Ethereum ETF with $204 million. Fidelity’s Ethereum Fund also saw significant interest, attracting $71 million in assets. These figures mirror the success of spot Bitcoin ETFs from the same issuers, indicating that established financial institutions are successfully leveraging their reputations to attract investors to crypto-based products.

An interesting development was the conversion of the Grayscale Ethereum Trust into an ETF. Despite launching with over $9 billion in assets, it experienced outflows of $484 million on its first day as an ETF. This outflow, significantly larger than what Grayscale’s converted Bitcoin ETF experienced in January, may be attributed to its higher fee structure compared to competitors. The market’s reaction suggests that investors are price-sensitive and willing to move their assets to more cost-effective options.

The introduction of Ethereum ETFs, following Bitcoin ETFs, represents a broader trend of cryptocurrencies gaining legitimacy in traditional financial markets. These products provide investors with exposure to digital assets without the complexities of direct ownership, such as wallet management and security concerns. This ease of access could potentially drive greater adoption of cryptocurrencies among both retail and institutional investors.

The impact of crypto ETFs on stock markets is multifaceted. Firstly, they provide a new asset class for investors to diversify their portfolios, potentially affecting allocations to traditional assets. Secondly, the performance of these ETFs could influence market sentiment, as cryptocurrencies are often seen as indicators of risk appetite. Lastly, the success of crypto ETFs may encourage more traditional financial institutions to develop crypto-related products, further blurring the lines between conventional and digital finance.

However, it’s important to note that the cryptocurrency market remains highly volatile, and regulatory scrutiny continues to evolve. The performance of these ETFs will likely be closely watched by investors and regulators alike, potentially influencing future policy decisions regarding digital assets.

Looking ahead, the success of Bitcoin and Ethereum ETFs may pave the way for similar products based on other cryptocurrencies. As the crypto ecosystem continues to mature, we may see ETFs tied to other major digital assets or even basket products that offer exposure to multiple cryptocurrencies.

In conclusion, the launch of Ethereum ETFs represents another step in the mainstream acceptance of cryptocurrencies. While it’s too early to determine their long-term impact, the strong initial interest suggests that investors are eager for regulated ways to gain exposure to digital assets. As the landscape continues to evolve, the interplay between cryptocurrencies and traditional financial markets will be an area of significant interest for investors, regulators, and market observers alike.

U.S. Housing Market Shifts Gears: June Sales Slump Signals Transition to Buyer’s Market

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Existing home sales dropped 5.4% in June, indicating a market slowdown
– Housing inventory increased by 23.4% year-over-year, yet prices continue to rise
– Market shows signs of transitioning from a seller’s to a buyer’s market

The U.S. housing market is showing signs of a significant shift, as June’s home sales data points to a cooling market and a potential transition favoring buyers. According to the latest report from the National Association of Realtors (NAR), sales of previously owned homes declined by 5.4% in June compared to May, reaching an annualized rate of 3.89 million units. This marks the slowest sales pace since December and represents a 5.4% decrease from June of the previous year.

The slowdown in sales can be largely attributed to the spike in mortgage rates, which surpassed 7% in April and May. Although rates have slightly retreated to the high 6% range, the impact on buyer behavior is evident. Lawrence Yun, chief economist for the NAR, noted, “We’re seeing a slow shift from a seller’s market to a buyer’s market.”

One of the most significant changes in the market is the substantial increase in housing inventory. The number of available homes jumped 23.4% year-over-year to 1.32 million units at the end of June. While this represents a considerable improvement from the record lows seen recently, it still only amounts to a 4.1-month supply, falling short of the six-month supply typically considered balanced between buyers and sellers.

The surge in inventory is partly due to homes remaining on the market for longer periods. The average time a home spent on the market increased to 22 days, up from 18 days a year ago. This extended selling time, coupled with buyers’ increasing insistence on home inspections and appraisals, further indicates a shift in market dynamics.

Interestingly, despite the increased supply and slower sales, home prices continue to climb. The median price of an existing home sold in June reached $426,900, marking a 4.1% increase year-over-year and setting an all-time high for the second consecutive month. However, this price growth is not uniform across all segments of the market.

The higher end of the market, particularly homes priced over $1 million, was the only category experiencing sales gains compared to the previous year. In contrast, the most significant drop in sales occurred in the $250,000 and lower range. This disparity highlights the ongoing affordability challenges in the housing market, especially for first-time buyers and those seeking lower-priced homes.

The changing market conditions are also influencing buyer behavior. Cash purchases increased to 28% of sales, up from 26% a year ago, while investor activity slightly decreased to 16% of sales from 18% the previous year. These trends suggest that well-funded buyers are still active in the market, potentially taking advantage of the increased inventory and longer selling times.

Looking ahead, the market’s trajectory remains uncertain. Yun suggests that if inventory continues to increase, one of two scenarios could unfold: either home sales will rise, or prices may start to decrease if demand doesn’t keep pace with supply. The influx of smaller and lower-priced listings, as noted by Danielle Hale, chief economist for Realtor.com, could help moderate overall price growth and potentially improve affordability for some buyers.

As the housing market navigates this transition, both buyers and sellers will need to adjust their strategies. Buyers may find more options and negotiating power, while sellers may need to be more flexible on pricing and terms. The coming months will be crucial in determining whether this shift towards a buyer’s market solidifies or if other factors, such as potential changes in mortgage rates or economic conditions, alter the market’s trajectory once again.

Release – Conduent Transportation Modernizes Ohio Turnpike’s Tolling Lanes to Improve Motorist Experience

Posted on by aweinsoff@channelchek.com

Research News and Market Data on CNDT

JULY 23, 2024

TRANSPORTATION

Spanning 241 miles, the turnpike now features open-road E-ZPass® tolling lanes and a gated exit system using Automated Toll Payment Machines

The modernization is the largest construction project in Ohio Turnpike history since the toll road was completed in 1955

FLORHAM PARK, N.J.– Conduent Transportation, a global provider of smart mobility technology solutions and business unit of Conduent Incorporated (Nasdaq: CNDT), today announced the completion of a modernized toll collection infrastructure for the Ohio Turnpike. Conduent upgraded 216 lanes on the 241-mile-long turnpike to include self-service and collector-operated toll plazas, as well as open-road, automated tolling options for vehicles using E-ZPass® transponders.

The new system, managed by the Ohio Turnpike and Infrastructure Commission (OTIC), will help increase traffic flow and vehicle throughput, while providing for operational efficiencies – all leading to more convenience and an improved experience for motorists. According to OTIC, the modernization is the largest construction project in Ohio Turnpike history since the toll road was completed in 1955.

“The Conduent team has shown great partnership, professionalism and expertise throughout our implementation and go-live of the modernized toll collection system on the Ohio Turnpike,” said Ferzan M. Ahmed, P.E., Executive Director at OTIC. “Working closely with our staff, Conduent has implemented Ohio’s first open road tolling system that will help increase traffic flow and provide operational efficiencies.”

As a key part of the implementation, Conduent installed and will maintain state-of-the-art, open-road tolling lanes for E-ZPass customers, and separate lanes with Automated Toll Payment Machines that accept coins, cash, and credit or debit cards. The machines will be equipped in the future to enable contactless payments using smartphones and digital wallets. The open-road tolling solution, meanwhile, incorporates LiDAR (Light Detection and Ranging)-based scanners with proven performance and accuracy. Automated License Plate Recognition technology will also be used to account for vehicles driving through E-ZPass lanes without a transponder.

“Since 2020, our team has partnered with OTIC to make this new tolling infrastructure a reality, and we are proud to complete such an important project on one of the longest-running toll roads in the country,” said Adam Appleby, Group President, Public Sector Solutions. “Today’s announcement reinforces our leadership in providing tolling solutions that bring lasting value for agencies and the customers who experience the true benefits of modern mobility.”

This Ohio project follows another recently announced implementation, in which Conduent launched an Express Lanes tolling system for the Virginia Department of Transportation (VDOT). That system enables flexible, dynamic pricing and license plate image reviews, helping to improve the flow of traffic and relieve congestion for VDOT.

Conduent Transportation is a leading provider of streamlined, high-volume mobility services and solutions, spanning road usage charging and advanced transit systems, that enhance the services provided by transportation agencies to benefit the citizens who use them. For over 50 years, the company has helped clients advance transportation solutions in more than 20 countries.

About Conduent

Conduent delivers digital business solutions and services spanning the commercial, government and transportation spectrum – creating valuable outcomes for its clients and the millions of people who count on them. The Company leverages cloud computing, artificial intelligence, machine learning, automation and advanced analytics to deliver mission-critical solutions. Through a dedicated global team of approximately 59,000 associates, process expertise and advanced technologies, Conduent’s solutions and services digitally transform its clients’ operations to enhance customer experiences, improve performance, increase efficiencies and reduce costs. Conduent adds momentum to its clients’ missions in many ways including disbursing approximately $100 billion in government payments annually, enabling 2.3 billion customer service interactions annually, empowering millions of employees through HR services every year and processing nearly 13 million tolling transactions every day. Learn more at www.conduent.com.

Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.

Trademarks

Conduent is a trademark of Conduent Incorporated in the United States and/or other countries. Other names may be trademarks of their respective owners.

Media Contacts

NEIL FRANZ

Conduent

neil.franz@conduent.com

+1-240-687-0127

GILES GOODBURN

Conduent

ir@conduent.com

+1-203-216-3546

Release – Century Lithium Changes Project Name to Angel Island Mine

Posted on by aweinsoff@channelchek.com

Research News and Market Data on CYDVF

July 23, 2024 – Vancouver, Canada – Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z)

Century Lithium (or the Company) announces it has changed the name of its 100%-owned Clayton Valley Lithium Project in Nevada, USA to the Angel Island Mine (the Project). In April 2024, the Company announced a positive Feasibility Study for the Project, making it one of the few advanced lithium projects being developed in the United States. As the Company now continues to work towards permitting the Project, regulators encouraged a name change for clarity in the permitting process. The Angel Island name distinguishes it from other mining and energy projects in the area by using the name of a topographical feature from the Project.

ABOUT ANGEL ISLAND

Angel Island is named for the ridge of older metavolcanic and clastic rocks bordering the west side of Century’s lithium clay deposit. The name itself dates to the 1800’s, one of three landforms in Clayton Valley named for islands in San Francisco Bay (Alcatraz and Goat islands being the other two). Of the three landforms, Angel Island is the largest, rising to a height 400 meters above the valley floor. Its presence on the east side of the valley, separating Century’s lithium clay deposit from the lithium brine operation of Albemarle Corp., is owed to uplift along a major northeast trending normal fault located along the western base of the ridge. Although not directly related to the formation of Century’s deposit, uplift of Angel Island along this fault was responsible for elevating the clay deposits east of the fault and bringing them to the surface where they are now accessible for mining. The harder rocks in the ridge also likely acted as a physical barrier protecting Century’s lithium clay deposit from erosion.

ABOUT CENTURY LITHIUM CORP.

Century Lithium Corp. is an advanced stage lithium company, focused on developing its 100%-owned Angel Island Mine in west-central Nevada, USA. Century Lithium recently completed a Feasibility Study on the Project and is currently in the permitting stage, with the goal of becoming a domestic producer of lithium for the growing electric vehicle and battery storage market.

ON BEHALF OF CENTURY LITHIUM CORP.
WILLIAM WILLOUGHBY, PhD., PE
President & Chief Executive Officer

For further information, please contact:
Spiros Cacos | Vice President, Investor Relations
Direct: +1 604 764 1851
Toll Free: 1 800 567 8181
scacos@centurylithium.com
centurylithium.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

Cautionary Note Regarding Forward-Looking Statements

This release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. In certain cases, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” and similar expressions suggesting future outcomes or statements regarding an outlook.

Forward-looking statements relate to any matters that are not historical facts and statements of our beliefs, intentions and expectations about developments, results and events which will or may occur in the future, without limitation, statements with respect to the potential development and value of the Project and benefits associated therewith, statements with respect to the expected project economics for the Project, such as estimates of life of mine, lithium prices, production and recoveries, capital and operating costs, IRR, NPV and cash flows, any projections outlined in the Feasibility Study in respect of the Project, the permitting status of the Project and the Company’s future development plans.

These and other forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause their actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out herein. These risks include those described under the heading “Risk Factors” in the Company’s most recent annual information form and its other public filings, copies of which can be under the Company’s profile at www.sedarplus.com. The Company expressly disclaims any obligation to update-forward-looking information except as required by applicable law. No forward-looking statement can be guaranteed, and actual future results may vary materially. Accordingly, readers are advised not to place reliance on forward-looking statements or information. Furthermore, Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.

Fed’s Cautious Approach: Two Rate Cuts Expected in 2024 Despite Market Optimism

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Economists predict two Fed rate cuts in 2024, less than market expectations
– Resilient consumer demand and strong labor market support a cautious approach
– Inflation easing but not expected to reach 2% target until at least 2026

In a recent Reuters poll, economists have outlined a more conservative outlook for Federal Reserve interest rate cuts compared to current market expectations. While financial markets are pricing in two to three rate reductions this year, a growing majority of economists anticipate only two cuts, scheduled for September and December 2024. This cautious stance reflects the complex interplay between easing inflation, robust consumer spending, and a resilient labor market.

The survey, conducted from July 17-23, revealed that over 80% of the 100 economists polled expect the first 25-basis-point cut to occur in September. This would bring the federal funds rate to the 5.00%-5.25% range. Nearly three-quarters of respondents predicted a second cut in December, maintaining this view for the past four months despite shifting market sentiments.

The rationale behind this conservative approach lies in the unexpected strength of the U.S. economy. June’s retail sales data surpassed expectations, indicating that consumer spending remains a powerful economic driver. Additionally, the unemployment rate, currently at 4.1%, is not projected to rise significantly. These factors suggest that the economy may not require as much monetary policy support as previously thought.

Inflation, while decelerating, continues to be a concern for policymakers. The personal consumption expenditures (PCE) price index, the Fed’s preferred inflation gauge, is expected to show only a slight decline to 2.5% in June from 2.6% in May. More importantly, economists don’t foresee inflation reaching the Fed’s 2% target until at least 2026, underscoring the persistent nature of price pressures.

The divergence between economist predictions and market expectations has notable implications. Recent market movements have seen stocks rise by around 2% and yields on 10-year Treasury notes fall by more than 25 basis points this month, reflecting optimism about potential rate cuts. However, the more measured outlook from economists suggests that market participants may need to temper their expectations.

Looking ahead, the Fed’s decision-making process will be heavily influenced by upcoming economic data. This week’s releases, including the second-quarter GDP growth rate and June’s PCE price index, will be crucial in shaping the economic landscape. Economists project Q2 GDP growth at an annualized rate of 2.0%, up from 1.4% in Q1, indicating continued economic expansion.

The long-term outlook suggests a gradual easing of monetary policy. Economists anticipate one rate cut per quarter through 2025, potentially bringing the federal funds rate to the 3.75%-4.00% range by the end of that year. This measured approach aligns with the Fed’s dual mandate of maintaining price stability and maximum employment.

It’s worth noting that the U.S. economy is expected to grow by 2.3% in 2024, surpassing the Fed’s estimated non-inflationary growth rate of 1.8%. This robust growth projection further supports the case for a cautious approach to rate cuts.

In conclusion, while the Federal Reserve has made progress in its fight against inflation, the path forward remains complex. The resilience of the U.S. consumer and labor market, coupled with stubborn inflationary pressures, necessitates a balanced approach to monetary policy. As we move through 2024, market participants and policymakers alike will need to closely monitor economic indicators to gauge the appropriate pace of monetary easing.